Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL.

被引：26

作者：

Moskowitz, Craig ^{[1
]}

Hamlin, Paul A. ^{[1
]}

Horwitz, Steven M. ^{[1
]}

Noy, Ariela ^{[1
]}

O'Connor, Owen A. ^{[1
]}

Palomba, M. Lia ^{[1
]}

Portlock, Carol S. ^{[1
]}

Straus, David J. ^{[1
]}

Chennin-Lessac, Simone ^{[1
]}

Weaver, Alandra ^{[1
]}

Teruva-Feldstein, Julie ^{[1
]}

Schoder, Heiko ^{[1
]}

Zelenetz, Andrew D. ^{[1
]}

机构：

[1] Lymphoma Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

关键词：

D O I：

10.1182/blood.V108.11.532.532

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

532

引用

页码：161A / 161A

页数：1